Table 2.
Intraoperative, pathological and postoperative factors.
| B (n = 32) | C (n = 93) | NBNC (n = 76) | P value | |
|---|---|---|---|---|
| ≧2 sentionectomy | 13 (40.6%) | 17 (18.3%) | 32 (42.1%) | 0.002 |
| Operative Time (min.) | 352 (177–658) | 333 (135–750) | 367 (173–983) | 0.142 |
| Blood loss (g) | 1137 (38–8488) | 1182 (5–8307) | 1226 (200–36000) | 0.590 |
| Curability R0 | 27 (84.4%) | 88 (94.6%) | 70 (92.1%) | 0.181 |
| Simple nodular type | 12 (37.5%) | 54 (58.1%) | 30 (39.5%) | 0.025 |
| Poorly differentiated | 6 (18.8%) | 14 (15.1%) | 6 (7.9%) | 0.218 |
| fc(+) | 24 (75.0%) | 63 (67.7%) | 44 (57.9%) | 0.182 |
| vp(+) | 17 (53.1%) | 24 (25.8%) | 28 (36.8%) | 0.016 |
| vv(+) | 5 (15.6%) | 4 (4.3%) | 7 (9.2%) | 0.109 |
| im(+) | 6 (18.8%) | 7 (7.5%) | 7 (9.2%) | 0.181 |
| Non-cancerous liver NL | 1 (3.1%) | 1 (1.1%) | 23 (30.3%) | <0.001 |
| CH | 17 (53.1%) | 44 (47.3%) | 29 (38.2%) | 0.288 |
| LC | 14 (43.8%) | 48 (51.6%) | 23 (30.3%) | 0.020 |
| Clavien-Dindo ≧ III | 5 (15.6%) | 19 (20.4%) | 12 (15.8%) | 0.688 |
| PHLF B/C | 7 (21.9%) | 28 (30.1%) | 18 (23.7%) | 0.526 |
| 90-day mortality | 4 (12.5%) | 6 (6.5%) | 6 (7.9%) | 0.552 |
| Intrahepatic recurrence | 13 (40.6%) | 47 (50.5%) | 25 (32.9%) | 0.068 |
| Extrahepatic recurrence | 7 (21.9%) | 8 (8.6%) | 7 (9.2%) | 0.096 |
fc: formation of capsule; vp: microscopic portal vein invasion; vv: microscopic hepatic vein invasion; im: intrahepatic metastasis; NL: normal liver; CH: chronic hepatitis; LC: liver cirrhosis; PHLF: posthepatectomy liver failure.